| SPAC | IPO Date | Role | Deal Size ($M) | Share | Book-Runner Credit ($M) | Volume Sold ($M) |
|---|---|---|---|---|---|---|
| Viscogliosi Brothers Acquisition Corp. | 1/7/2022 | sole book-runner | 86.3 | 1 | 86.3 | 75.0 |
| 86.3 | 75.0 |
| SPAC | IPO Date | Role | Deal Size ($M) | Share | Book-Runner Credit ($M) | Volume Sold ($M) |
|---|---|---|---|---|---|---|
| JATT Acquisition Corp | 7/14/2021 | sole book-runner | 138.0 | 1 | 138.0 | 120.0 |
| Ibere Pharmaceuticals | 2/26/2021 | sole book-runner | 138.0 | 1 | 138.0 | 120.0 |
| Warrior Technologies Acquisition Company | 2/26/2021 | lead left | 276.0 | 1/2 | 138.0 | 120.0 |
| 414.0 | 360.0 |
| SPAC | IPO Date | Role | Deal Size ($M) | Share | Book-Runner Credit ($M) | Volume Sold ($M) |
|---|---|---|---|---|---|---|
| MedTech Acquisition Corporation | 12/18/2020 | sole book-runner | 250.0 | 1 | 250.0 | 220.0 |
| Recharge Acquisition Corp. | 10/1/2020 | lead left | 200.4 | 1/2 | 100.2 | 100.0 |
| Northern Genesis Acquisition Corp. | 8/18/2020 | lead left | 319.5 | 1/2 | 159.7 | 150.0 |
| 509.9 | 470.0 |
| SPAC | IPO Date | Role | Deal Size ($M) | Share | Book-Runner Credit ($M) | Volume Sold ($M) |
|---|---|---|---|---|---|---|
| LF Capital Acquisition Corp. | 6/20/2018 | 155.3 | 44.6 | |||
| 0.0 | 44.6 |
Credit for Book-Runner Credit ($M) is based on the total amount of the offering sold, including over-allotment. Full credit is awarded to the sole book-runner or split equally among joint book-runners.